Drug Type Small molecule drug |
Synonyms AS/SP, Co-Arinate, Coarinate |
Mechanism ATP2A1 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors), DHFR inhibitors(Dihydrofolate reductase inhibitors), DHPS inhibitors(Dihydropteroate synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC19H28O8 |
InChIKeyFIHJKUPKCHIPAT-AHIGJZGOSA-N |
CAS Registry88495-63-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Malaria | - | - |
Phase 3 | 1,390 | artesunate-sulphamethoxypyrazine-pyrimethamine three-day regimen | dmlzzqudzu(cnmjsweofj) = scwhopplte vfixpqhzfg (wbkmahjhly ) | - | 14 Apr 2009 | ||
artesunate-sulphamethoxypyrazine-pyrimethamine 24-hour regimen | dmlzzqudzu(cnmjsweofj) = hwakjpbubz vfixpqhzfg (wbkmahjhly ) |